Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00608387 · ClinicalTrials.gov registry record · NA

Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians

A NA study of Obesity and Hypertension, sponsored by Black Hills Center for American Indian Health.

Completed
Registry status
NA
Development phase
149
Enrollment target
1
Study location

NCT00608387: Completed NA study of Obesity and Hypertension, sponsored by Black Hills Center for American Indian Health.

NCT00608387 is a NA study of Obesity and Hypertension that has completed, run by Black Hills Center for American Indian Health. The registered enrollment target is 149 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00608387, a NA study of Obesity and Hypertension, has completed, sponsored by Black Hills Center for American Indian Health.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease (CVD) is a serious health concern for American Indians, but there have been few behaviorally based programs to lessen CVD risk among this population. The purpose of this study is to evaluate whether a Web-based program, in addition to usual medical care, can lower CVD risk factors among American Indians who have type 2 diabetes and a high risk of developing CVD.

Interventions

  • BEHAVIORAL Chronic disease management Web-based software

Study Locations (1)

South Dakota

  • Black Hills Center for American Indian Health - Rapid City

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2009-02
Est. Completion 2012-06
Phase NA

What the finished NCT00608387 record still lists

NCT00608387 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Chronic disease management Web-based software is the first listed.

NCT00608387 reports a single indexed study location in South Dakota.

Frequently Asked Questions

What is clinical trial NCT00608387 about?

NCT00608387 is a clinical study titled "Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians". Cardiovascular disease (CVD) is a serious health concern for American Indians, but there have been few behaviorally based programs to lessen CVD risk among this population. The purpose of this study is to evaluate whether a Web-based program, in addition to usual medical care, can lower CVD risk fac...

What is the current status of trial NCT00608387?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2009-02. Estimated completion is 2012-06.

What conditions does trial NCT00608387 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Tobacco Use Cessation.

What interventions are being tested in trial NCT00608387?

The interventions under investigation include: Chronic disease management Web-based software (BEHAVIORAL).

Who is sponsoring clinical trial NCT00608387?

This trial is sponsored by Black Hills Center for American Indian Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00608387 being conducted?

This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00608387's enrollment target sits among peer trials

149 387th of 1053 higher than 666 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00608387, the US trial registry maintained by the National Library of Medicine. NCT00608387 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.